Back
Pasithea Therapeutics Corp. 10K Form
Buy
67
KTTA
Pasithea Therapeutics Corp.
Last Price:
$1.16
Seasonality Move:
-5.84%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive KTTA News And Ratings
See the #1 stock for the next 7 days that we like better than KTTA
KTTA Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-2.9M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.64 |
| Price / Book: | 0.71 |
Profitability
| EPS (TTM): | -5.08230 |
|---|---|
| Net Income (TTM): | $-13.5M |
| Gross Margin: | $-649K |
| Return on Equity: | -92.48% |
| Return on Assets: | -84.34% |
Pasithea Therapeutics Corp. Earnings Forecast
Key Pasithea Therapeutics Corp. Financial Ratios
-
Per Share Earnings over the last 4 years have been positive in 1 years.
Pasithea Therapeutics Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | KTTA |
| Website: | pasithea.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 4.02 |
| Quick Ratio: | 3.07 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
KTTA Technical Analysis vs Fundamental Analysis
Buy
67
Pasithea Therapeutics Corp. (KTTA)
is a Buy
Is Pasithea Therapeutics Corp. a Buy or a Sell?
-
Pasithea Therapeutics Corp. stock is rated a BuyThe current Pasithea Therapeutics Corp. [KTTA] share price is $1.18. The Score for KTTA is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.